Literature DB >> 26338994

Antigen Selection Shapes the T-cell Repertoire in Chronic Lymphocytic Leukemia.

Anna Vardi1, Andreas Agathangelidis2, Evangelia Stalika1, Maria Karypidou3, Alexandra Siorenta4, Achilles Anagnostopoulos5, Richard Rosenquist6, Anastasia Hadzidimitriou1, Paolo Ghia2, Lesley-Ann Sutton7, Kostas Stamatopoulos8.   

Abstract

PURPOSE: The role of antigen(s) in shaping the T-cell repertoire in chronic lymphocytic leukemia, although relevant for understanding malignant cell interactions with cognate T cells, is largely unexplored. EXPERIMENTAL
DESIGN: Here we profiled the T-cell receptor β chain gene repertoire in 58 chronic lymphocytic leukemia patients, focusing on cases assigned to well-characterized subsets with stereotyped clonotypic B-cell receptor immunoglobulins, therefore those cases most evidently selected by antigen (subsets #1, #2, and #4).
RESULTS: Remarkable repertoire skewing and oligoclonality were observed, and differences between subsets were noted regarding both T-cell receptor β chain gene usage and the extent of clonality, with subset #2 being the least oligoclonal. Longitudinal analysis of subset #4 cases revealed that although the repertoire may fluctuate over time, certain clonotypes persist, thus alluding to persistent antigenic stimulation. Shared ("stereotyped") clonotypes were found between different patients, reflecting selection by common antigenic elements. Cross-comparison of our dataset with public databases showed that some T-cell clonotypes may have expanded secondary to common viral infections; however, the majority of clonotypes proved to be disease-specific.
CONCLUSIONS: Overall, the T-cell receptor β chain repertoire in chronic lymphocytic leukemia is likely shaped by antigen selection and the implicated antigenic elements may concern epitopes that also select the malignant B-cell progenitors or, more intriguingly, chronic lymphocytic leukemia-derived epitopes. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26338994     DOI: 10.1158/1078-0432.CCR-14-3017

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

1.  Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia.

Authors:  Qingsong Yin; Mariela Sivina; Harlan Robins; Erik Yusko; Marissa Vignali; Susan O'Brien; Michael J Keating; Alessandra Ferrajoli; Zeev Estrov; Nitin Jain; William G Wierda; Jan A Burger
Journal:  J Immunol       Date:  2017-01-11       Impact factor: 5.422

2.  Restrictions in the T-cell repertoire of chronic lymphocytic leukemia: high-throughput immunoprofiling supports selection by shared antigenic elements.

Authors:  A Vardi; E Vlachonikola; M Karypidou; E Stalika; V Bikos; K Gemenetzi; C Maramis; A Siorenta; A Anagnostopoulos; S Pospisilova; N Maglaveras; I Chouvarda; K Stamatopoulos; A Hadzidimitriou
Journal:  Leukemia       Date:  2016-11-25       Impact factor: 11.528

3.  Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL.

Authors:  Gonzalo Blanco; Anna Vardi; Anna Puiggros; Andrea Gómez-Llonín; Manuel Muro; María Rodríguez-Rivera; Evangelia Stalika; Eugenia Abella; Eva Gimeno; Manuela López-Sánchez; Alicia Senín; Xavier Calvo; Pau Abrisqueta; Francesc Bosch; Ana Ferrer; Kostas Stamatopoulos; Blanca Espinet
Journal:  Oncoimmunology       Date:  2018-02-20       Impact factor: 8.110

4.  Activation and expansion of T-follicular helper cells in chronic lymphocytic leukemia nurselike cell co-cultures.

Authors:  Alicia M Vaca; Nikolaos Ioannou; Mariela Sivina; Elisavet Vlachonikola; Karen Clise-Dwyer; Ekaterina Kim; Dan Li; Qing Ma; Alessandra Ferrajoli; Zeev Estrov; William G Wierda; Piers E M Patten; Alan G Ramsay; Jan A Burger
Journal:  Leukemia       Date:  2022-02-11       Impact factor: 11.528

5.  Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment.

Authors:  Iris de Weerdt; Tom Hofland; Renate de Boer; Johan A Dobber; Julie Dubois; Denise van Nieuwenhuize; Mehrdad Mobasher; Fransien de Boer; Mels Hoogendoorn; Gerjo A Velders; Marjolein van der Klift; Ester B M Remmerswaal; Frederike J Bemelman; Carsten U Niemann; Sabina Kersting; Mark-David Levin; Eric Eldering; Sanne H Tonino; Arnon P Kater
Journal:  Blood Adv       Date:  2019-09-10

6.  Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia.

Authors:  Georg Aue; Clare Sun; Delong Liu; Jae-Hyun Park; Stefania Pittaluga; Xin Tian; Elinor Lee; Susan Soto; Janet Valdez; Irina Maric; Maryalice Stetler-Stevenson; Constance Yuan; Yusuke Nakamura; Pawel Muranski; Adrian Wiestner
Journal:  J Immunol       Date:  2018-08-13       Impact factor: 5.422

7.  Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues.

Authors:  Bola S Hanna; Philipp M Roessner; Haniyeh Yazdanparast; Dolors Colomer; Elias Campo; Sabrina Kugler; Deyan Yosifov; Stephan Stilgenbauer; Manfred Schmidt; Richard Gabriel; Peter Lichter; Martina Seiffert
Journal:  Leukemia       Date:  2018-09-28       Impact factor: 11.528

8.  Distinct immune signatures in chronic lymphocytic leukemia and Richter syndrome.

Authors:  Yucai Wang; Sutapa Sinha; Linda E Wellik; Charla R Secreto; Karen L Rech; Timothy G Call; Sameer A Parikh; Saad S Kenderian; Eli Muchtar; Suzanne R Hayman; Amber B Koehler; Daniel L Van Dyke; Jose F Leis; Susan L Slager; Haidong Dong; Neil E Kay; Rong He; Wei Ding
Journal:  Blood Cancer J       Date:  2021-05-10       Impact factor: 11.037

9.  IRProfiler - a software toolbox for high throughput immune receptor profiling.

Authors:  Christos Maramis; Athanasios Gkoufas; Anna Vardi; Evangelia Stalika; Kostas Stamatopoulos; Anastasia Hatzidimitriou; Nicos Maglaveras; Ioanna Chouvarda
Journal:  BMC Bioinformatics       Date:  2018-04-18       Impact factor: 3.169

10.  T cells in chronic lymphocytic leukemia: can they fight?

Authors:  Anna Vardi; Kostas Stamatopoulos; Anastasia Hadzidimitriou
Journal:  Oncotarget       Date:  2017-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.